Bryan Dickinson to Drug Repositioning
This is a "connection" page, showing publications Bryan Dickinson has written about Drug Repositioning.
Connection Strength
0.047
-
Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays. Methods. 2021 11; 195:57-71.
Score: 0.047